IHA Logo
IHA News
A A A

IHA News

Science Paper published

A recent Science article published by a team of UCL researchers including the IHA's Dr Teresa Niccoli sheds light into toxicity mechanisms. View the article here: http://goo.gl/2sgNCb More...

Published: Aug 19, 2014 10:24:04 AM

Knudra Transgenics prize success for IHA

In a recent competition organised by the biotech company KNUDRA TRANSGENICS three members of the IHA were awarded prizes to make custom transgenic animals.

Second prize $3000 to Nuria Vergara to develop the project "Can human FOXO3a replace DAF-16 to promote longevity in C. elegans?" using CRSPR technology.

Third prize £1500 to Jennifer Tullet to investigate "How do translational errors affect longevity and health in C. elegans?"

Sixth prize $500 to Lamia Mestek to expand our knowledge in "Understanding the role of DAF-16 transcription factor in longevity"

The results of the competition can be checked in the following link: http://knudragrants.knudra.com/?page_id=39

Congratulations to all the winners!!!
More...

Published: Aug 19, 2014 10:10:57 AM

New Wellcome Trust video 'Until' features IHA scientists

The Wellcome Trust’s online publication, Mosaic, have released a new video ‘Until’, an exploration of ageing which asks the question, ‘how long would you like to live?’. The video includes interviews with leading ageing scientists (including the IHA's David Gems and Linda Partridge), transhumanists, elderly people and the young children and asks them when they think would be an appropriate time to die, if they had the choice. It also explores the possibilities and realities of extended lifespans in the future. The video can be found here: http://youtu.be/BsUZHyh4n-c More...

Published: Aug 6, 2014 11:44:15 AM

Fiona Kerr - Alzheimer's Association International Conference highlights

23 July 2012

Dr Fiona Kerr (Partridge Lab) attended the AAIC in Vancouver, 14th-19th July 2012 last week.

Fiona writes: Over the last three years Genome Wide Association Studies (GWAS) have led to the discovery of variants in 10 new genes which associate with increased risk of developing late-onset Alzheimer’s disease (LOAD). This has required an unprecedented level of collaboration within the AD field, pulling together clinical cohorts world-wide in order to achieve the large data-sets required to obtain meaningful findings in such studies. At this year’s AAIC the excitement re-instated in Alzheimer’s by this research was evident, with scientists looking toward the post-GWAS era of AD discovery. We need to understand more about the effect of these AD-risk variants on gene expression and function, and their potential role in the development of Alzheimer’s disease pathology. If any of these genes are found to play a causal role in AD pathogenesis, beyond simply associating with increased risk for disease development, this could uncover potential new therapeutic targets for the prevention and treatment of LOAD.

Page last modified on 23 jul 12 13:34